Actively Recruiting
Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
Led by Johannes Kepler University of Linz · Updated on 2023-10-10
500
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are exploring new diagnostic possibilities for eye diseases using a novel imaging technique called Swept Source Optical Coherence Tomography (SS-OCT). This pilot observational study aims to gather detailed information on disease mechanisms, progression, and potential future management for patients with retinal diseases, including diabetic retinopathy and macular degeneration. The study is sponsored by Johannes Kepler University of Linz and involves participants aged 5 to 110 years. The study uses the commercially available SS-OCT system Plex Elite 9000 to capture detailed images of the eye's morphology. This technology allows researchers to monitor structural changes in the retina over the course of approximately one year. The imaging procedures are non-invasive and are designed to be followed easily by participants who can comply with the instructions. Participants will undergo regular imaging sessions with the SS-OCT system to track morphological changes in their eyes. The study focuses on measuring these changes as a primary outcome to better understand disease progression. All participants must provide written informed consent, and their ability to follow imaging instructions will be assessed. The trial allows healthy volunteers and continues until December 2026, with an average follow-up duration of about one year.
CONDITIONS
Brief Title
Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 5 and 110 years
- Ability to follow instructions during imaging procedure
- Written Informed consent
You will not qualify if you...
- Dementia
- Inability to follow instructions during imaging procedure
- Patients who do not give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 year
Participants undergo imaging using the Swept Source Optical Coherence Tomography system to assess morphological changes in ophthalmological diseases.
1 or more visits depending on imaging schedule
Trial Site Locations
Total: 1 location
1
Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
Linz, Upper Austria, Austria, 4020
Actively Recruiting
Research Team
M
Matthias Bolz, Prof. Dr.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here